Tomasz Rechciński

1.0k total citations
78 papers, 757 citations indexed

About

Tomasz Rechciński is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Immunology. According to data from OpenAlex, Tomasz Rechciński has authored 78 papers receiving a total of 757 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 32 papers in Surgery and 22 papers in Immunology. Recurrent topics in Tomasz Rechciński's work include Helicobacter pylori-related gastroenterology studies (23 papers), Galectins and Cancer Biology (15 papers) and Heart Rate Variability and Autonomic Control (12 papers). Tomasz Rechciński is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (23 papers), Galectins and Cancer Biology (15 papers) and Heart Rate Variability and Autonomic Control (12 papers). Tomasz Rechciński collaborates with scholars based in Poland, Sweden and India. Tomasz Rechciński's co-authors include Magdalena Chmiela, Maria Krzemińska‐Pakuła, Małgorzata Kurpesa, Ewa Trzos, Karina Wierzbowska‐Drabik, Jarosław D. Kasprzak, Wiesława Rudnicka, Michał Plewka, Jan Z. Peruga and Agnieszka Matusiak and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Tomasz Rechciński

71 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Rechciński Poland 17 337 261 231 89 83 78 757
Datis Kharrazian United States 11 147 0.4× 87 0.3× 120 0.5× 24 0.3× 140 1.7× 23 919
Rubin Zhang United States 20 368 1.1× 74 0.3× 82 0.4× 21 0.2× 195 2.3× 48 1.1k
Yi‐Chu Chen Taiwan 9 347 1.0× 46 0.2× 43 0.2× 18 0.2× 29 0.3× 24 553
Jing Kong China 19 337 1.0× 56 0.2× 100 0.4× 29 0.3× 99 1.2× 51 825
Alejandro González Spain 16 99 0.3× 187 0.7× 85 0.4× 15 0.2× 76 0.9× 51 861
Laurent Jacob France 9 162 0.5× 48 0.2× 125 0.5× 35 0.4× 43 0.5× 27 425
Benjamin J. Freda United States 9 135 0.4× 338 1.3× 38 0.2× 118 1.3× 69 0.8× 12 594
George Karamanolis Greece 21 1.0k 3.1× 35 0.1× 70 0.3× 70 0.8× 170 2.0× 73 1.7k
C. F. Stanford United Kingdom 16 72 0.2× 390 1.5× 55 0.2× 25 0.3× 67 0.8× 47 885
Tobias Traeger Germany 15 105 0.3× 63 0.2× 254 1.1× 7 0.1× 119 1.4× 25 640

Countries citing papers authored by Tomasz Rechciński

Since Specialization
Citations

This map shows the geographic impact of Tomasz Rechciński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Rechciński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Rechciński more than expected).

Fields of papers citing papers by Tomasz Rechciński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Rechciński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Rechciński. The network helps show where Tomasz Rechciński may publish in the future.

Co-authorship network of co-authors of Tomasz Rechciński

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Rechciński. A scholar is included among the top collaborators of Tomasz Rechciński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Rechciński. Tomasz Rechciński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gonciarz, Weronika, et al.. (2024). Helicobacter pylori components increase the severity of metabolic syndrome and its hepatic manifestations induced by a high fat diet. Scientific Reports. 14(1). 5764–5764. 8 indexed citations
3.
Kurpesa, Małgorzata, et al.. (2024). Adverse events during a cardiac telerehabilitation program: A single-center study. Kardiologia Polska. 82(9). 886–888.
5.
Rechciński, Tomasz. (2023). What Else Can AI See in a Digital ECG?. Journal of Personalized Medicine. 13(7). 1059–1059. 1 indexed citations
6.
Gajewski, Adrian, Agnieszka Krupa, Tomasz Rechciński, et al.. (2022). Accumulation of Deleterious Effects in Gastric Epithelial Cells and Vascular Endothelial Cells In Vitro in the Milieu of Helicobacter pylori Components, 7-Ketocholesterol and Acetylsalicylic Acid. International Journal of Molecular Sciences. 23(11). 6355–6355. 8 indexed citations
7.
Gonciarz, Weronika, Agnieszka Krupa, Tomasz Rechciński, et al.. (2022). Antibodies towards TVLLPVIFF Amino Acid Sequence of TNF Receptor Induced by Helicobacter pylori in Patients with Coronary Heart Disease. Journal of Clinical Medicine. 11(9). 2545–2545. 6 indexed citations
9.
Rechciński, Tomasz, Bożena Szymańska, Karina Wierzbowska‐Drabik, et al.. (2021). Polymorphism of Interleukin-1 Gene Cluster in Polish Patients with Acute Coronary Syndrome. Journal of Clinical Medicine. 10(5). 990–990. 3 indexed citations
10.
Rechciński, Tomasz & Jarosław D. Kasprzak. (2020). Not only ISCHEMIA — report from AHA Scientific Sessions, Philadelphia, 16–18 November 2019. Folia Cardiologica. 15(1). 88–91. 1 indexed citations
11.
Rechciński, Tomasz, P Siedlecki, Ewa Trzos, et al.. (2020). FLOW-MEDIATED SKIN FLUORESCENCE (FMSF): A NOVEL METHOD FOR THE ESTIMATION OF SLEEP APNEA RISK IN HEALTHY PERSONS AND CARDIAC PATIENTS. Journal of the American College of Cardiology. 75(11). 3580–3580. 1 indexed citations
12.
Rechciński, Tomasz & Jarosław D. Kasprzak. (2020). Nie tylko ISCHEMIA. Sprawozdanie z American Heart Association’s Scientific Sessions 2019, Filadelfia 16–18 listopada 2019 roku. Folia Cardiologica. 15(1). 84–87.
13.
Wierzbowska‐Drabik, Karina, et al.. (2017). Diabetes as an independent predictor of left ventricular longitudinal strain reduction at rest and during dobutamine stress test in patients with significant coronary artery disease. European Heart Journal - Cardiovascular Imaging. 19(11). 1276–1286. 16 indexed citations
14.
Wierzbowska‐Drabik, Karina, et al.. (2016). Circumferential strain of carotid arteries does not differ between patients with advanced coronary artery disease and group without coronary stenoses. Advances in Medical Sciences. 61(2). 203–206. 7 indexed citations
15.
Wierzbowska‐Drabik, Karina, Małgorzata Kurpesa, Ewa Trzos, et al.. (2013). Echocardiographic indices of left ventricular hypertrophy and diastolic function in hypertensive patients with preserved LVEF classified as dippers and non-dippers. Archives of Medical Science. 2(2). 268–275. 17 indexed citations
16.
Rechciński, Tomasz, et al.. (2013). One patient — many faces of myocardial ischaemia. Kardiologia Polska. 71(6). 631–633. 1 indexed citations
17.
Fiszer, Marta, et al.. (2007). [The application of 4-aminopyridine in calcium channel inhibitors acute poisoning].. PubMed. 64(4-5). 293–7. 6 indexed citations
18.
Rechciński, Tomasz, Leokadia Bąk‐Romaniszyn, Elżbieta Czkwianianc, et al.. (2006). Potential role of LPS in the outcome of Helicobacter pylori related diseases.. PubMed. 55(1). 25–30. 16 indexed citations
19.
Chmiela, Magdalena, Magdalena Kowalewicz‐Kulbat, Tomasz Rechciński, et al.. (2003). A link betweenHelicobacter pyloriand/orChlamydiaspp. infections and atherosclerosis. FEMS Immunology & Medical Microbiology. 36(3). 187–192. 24 indexed citations
20.
Chmiela, Magdalena, et al.. (1999). Anti-Lewis X IgM and IgG in H. pylori infections in children and adults.. PubMed. 48(3). 277–81. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026